Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.

Almazrou, Saja H; Almalki, Ziyad S; Alanazi, Abdullah S; Alqahtani, Abdulhadi M; Alghamd, Saleh M

Almazrou, Saja H; Almalki, Ziyad S; Alanazi, Abdullah S; Alqahtani, Abdulhadi M; Alghamd, Saleh M.

Afiliación

Almazrou SH; Clinical Pharmacy Department, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Almalki ZS; Clinical Pharmacy Department, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, Riyadh, Saudi Arabia.
Alanazi AS; Clinical Pharmacy Department, College of Pharmacy, Jouf University, Al-Jouf, Saudi Arabia.
Alqahtani AM; Clinical Research Department, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Alghamd SM; Clinical Research Department, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Saudi Pharm J ; 28(12): 1877-1882, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33020690

Palabras clave

COVID-19; COVID-19, Coronavirus Disease 2019; Cohort study; Coronavirus disease; HCQ, Hydroxychloroquine; HESN, Health Electronic Surveillance Network; Hydroxychloroquine; ICU, intensive care unit; MOH, Ministry of Health; PMAH, Prince Mohammed bin Abdul Aziz Hospital; SC, Standard care; Saudi Arabia; WHO, World health organization

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: Saudi Pharm J Año: 2020 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google